Evidence map›Paper›PMID 41955426›Full record

ArticleBioinformatics (Oxford, England)2026

NumMolFormer: an explicit functional group number-guided framework for structure-based drug design.

Zhicun Zeng, Yifan Wu, Zhangli Lu, Min Li

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhicun ZengSchool of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, China.
Yifan WuSchool of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, China.
Zhangli LuSchool of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, China.
Min LiSchool of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, China.ORCID 0000-0002-0188-1394

Funding

High Performance Computing Center of Central South UniversityHunan Provincial Natural Science Foundation of China 2025JJ30025National Natural Science Foundation of China 62225209
6 · The paper itself

Abstract

motivationRational molecule generation that balances binding affinity with favorable physicochemical properties remains a formidable challenge in structure-based drug design. The number of functional groups is a key determinant, as over-functionalization compromises physicochemical properties, whereas under-functionalization reduces binding affinity. However, current methods are limited in their capacity to incorporate the constraint.

resultsTo address this, we present NumMolFormer, a Transformer-based framework designed to explicitly model functional group numbers. NumMolFormer adopts a dual-sequence input strategy, integrated with a numerical embedding module and a dual-stream differential attention mechanism, allowing molecular structures and functional group numbers to be encoded separately. This formulation alleviates the inherent limitations of standard Transformer in handling numerical information. In addition, we construct a large-scale dataset of 18 million molecules with functional group annotations for molecular pre-training, and further fine-tune the model using a combination of self-supervised learning and reinforcement learning under protein pocket constraints. The results demonstrate that NumMolFormer effectively leverages functional group information to generate molecules with improved binding affinity, synthetic accessibility, and drug-likeness compared to baseline methods. AVAILABILITY AND IMPLEMENTATION: The source code and datasets are available at http://www.github.com/zengzhicun/nummolformer.

Indexed as

Computational BiologyDrug DesignSoftwareProteinsProteins

Identifiers

PMID41955426
PMCPMC13107960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.